V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008012 | 10004073 | 1.74 | 76.6 | Curative (C) | 2018-10-23 | 2019-03-09 | FLUOROURACIL + IRINOTECAN | 02 | N | 10377269 | IRINOTECAN + MDG |
| 10008013 | 10004076 | 1.79 | 68.4 | Adjuvant (A) | 2017-12-01 | 2017-12-02 | FLUOROURACIL + OXALIPLATIN | 2 | N | 10377488 | OXALIPLATIN + MDG |
| 10008014 | 10004080 | 1.6 | 46.9 | Curative (C) | 2018-08-02 | 2018-10-30 | CAPECITABINE + OXALIPLATIN | 2 | N | 10377922 | CAPECITABINE + OXALIPLATIN |
| 10008015 | 10007151 | null | 62 | Curative (C) | 2018-10-06 | 2018-12-01 | Trastuzumab Subcutaneous | N | null | 10378220 | TRASTUZUMAB |
| 10008016 | 10004083 | 0 | 61.6 | Palliative (P) | 2019-07-29 | 2019-08-03 | Rituximab (Maintenance) | N | N | 10378293 | RITUXIMAB |
| 10008017 | 10004085 | null | 80.2 | Adjuvant (A) | 2014-11-21 | 2014-12-02 | Docetaxel | 02 | N | 10378613 | DOCETAXEL |
| 10008018 | 10004087 | 1.71 | 76.3 | Disease modification (D) | 2019-02-21 | 2019-02-22 | Capecitabine + Oxaliplatin 21day | N | N | 10378970 | CAPECITABINE + OXALIPLATIN |
| 10008019 | 10004090 | null | 94 | Palliative (P) | 2016-03-04 | 2016-03-05 | FLUOROURACIL + IRINOTECAN | 02 | N | 10379009 | IRINOTECAN + MDG |
| 10008020 | 10004091 | 1.69 | 57 | Curative (C) | 2018-01-23 | 2018-01-30 | Trastuzumab Subcutaneous | null | null | 10379515 | TRASTUZUMAB |
| 10008021 | 10004094 | 1.75 | null | Curative (C) | 2011-05-04 | 2015-06-30 | PACLITAXEL | N | N | 10379596 | PACLITAXEL |
| 10008022 | 10004097 | null | 104 | null | 2018-05-09 | 2018-07-16 | PACLITAXEL | N | null | 10379614 | PACLITAXEL |
| 10008023 | 10004098 | 1.68 | 64.9 | Disease modification (D) | 2018-03-11 | 2018-04-03 | TRASTUZUMAB | N | N | 10379624 | TRASTUZUMAB |
| 10008024 | 10004100 | 1.74 | 78.8 | Curative (C) | null | 2018-07-02 | Trastuzumab Subcutaneous | N | N | 10380108 | TRASTUZUMAB |
| 10008025 | 10004102 | 1.66 | 60 | null | 2017-12-17 | 2018-01-11 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 10380124 | PACLITAXEL |
| 10008026 | 10004105 | 1.57 | 93 | Palliative (P) | 2014-10-04 | 2014-11-02 | Irinotecan + Modified De Gramont | N | N | 10380133 | IRINOTECAN + MDG |
| 10008027 | 10004109 | 1.65 | 54 | Adjuvant (A) | 2017-08-04 | 2017-08-10 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10380173 | PACLITAXEL |
| 10008028 | 10007161 | 1.6 | 49 | Palliative (P) | 2014-12-27 | 2015-03-21 | Rituximab (Maintenance) | N | N | 10380355 | RITUXIMAB |
| 10008029 | 10004115 | 1.76 | 72.5 | Palliative (P) | 2017-01-27 | 2017-02-24 | Docetaxel | N | N | 10380457 | DOCETAXEL |
| 10008030 | 10004117 | 1.79 | 84.5 | Disease modification (D) | 2016-12-29 | 2017-01-11 | Rituximab | 2 | N | 10380618 | RITUXIMAB |
| 10008031 | 10004118 | 1.7 | 82.5 | Palliative (P) | 2015-08-08 | 2015-12-23 | Oxaliplatin + Modified de Gramont | N | N | 10380618 | OXALIPLATIN + MDG |
| 10008032 | 10004119 | 1.54 | null | Not known (9) | 2017-12-20 | 2018-08-23 | PACLITAXEL | 02 | N | 10380792 | PACLITAXEL |
| 10008033 | 10004122 | 1.73 | 69.9 | Curative (C) | 2017-05-12 | 2017-05-17 | TRASTUZUMAB | N | N | 10381565 | TRASTUZUMAB |
| 10008034 | 10004123 | 1.8 | 78.7 | Palliative (P) | 2017-10-31 | 2017-11-25 | Trastuzumab Subcutaneous | N | N | 10381987 | TRASTUZUMAB |
| 10008035 | 10008932 | 1.7 | 130.7 | Curative (C) | 2018-09-18 | 2018-09-20 | PEMBROLIZUMAB | 02 | N | 10382154 | PEMBROLIZUMAB |
| 10008036 | 10004126 | 1.84 | 81 | Curative (C) | 2016-09-28 | 2016-10-01 | Trastuzumab Subcutaneous | N | N | 10382324 | TRASTUZUMAB |
| 10008037 | 10004131 | 1.75 | 92.3 | null | 2018-08-01 | 2018-08-01 | Rituximab | 2 | N | 10382905 | RITUXIMAB |
| 10008038 | 10004133 | 1.75 | 93 | Palliative (P) | 2018-02-09 | 2018-02-11 | Capecitabine + Oxaliplatin 21day | 2 | N | 10383186 | CAPECITABINE + OXALIPLATIN |
| 10008039 | 10004139 | 1.7 | 68 | Palliative (P) | 2017-02-08 | 2018-06-08 | Rituximab | 02 | N | 10385236 | RITUXIMAB |
| 10008040 | 10004140 | null | 76.6 | Palliative (P) | 2012-07-23 | 2014-08-29 | Oxaliplatin + Modified de Gramont | 02 | N | 10385370 | OXALIPLATIN + MDG |
| 10008041 | 10004142 | 1.7 | 74 | null | 2017-10-01 | 2018-10-04 | Docetaxel 75mg/m2 (21 day) | N | null | 10385413 | DOCETAXEL |
| 10008042 | 10004145 | 1.77 | null | Adjuvant (A) | 2016-07-06 | 2017-07-25 | Paclitaxel 7 day | 2 | N | 10385482 | PACLITAXEL |
| 10008043 | 10004145 | 1.76 | 78 | Palliative (P) | 2016-06-19 | 2016-08-03 | Capecitabine + Oxaliplatin 21day | N | N | 10385482 | CAPECITABINE + OXALIPLATIN |
| 10008044 | 10007176 | 1.74 | 92.1 | null | 2018-11-25 | 2018-11-25 | TRASTUZUMAB | 02 | N | 10386223 | TRASTUZUMAB |
| 10008045 | 10004148 | 1.57 | 72 | Palliative (P) | 2017-11-08 | 2019-01-15 | Oxaliplatin + Modified de Gramont | N | N | 10386391 | OXALIPLATIN + MDG |
| 10008046 | 10004149 | null | 59.5 | Curative (C) | null | 2018-11-14 | Capecitabine + Oxaliplatin 14day | 2 | null | 10386550 | CAPECITABINE + OXALIPLATIN |
| 10008047 | 10004150 | 0 | 109 | Palliative (P) | 2019-01-19 | 2019-02-02 | R GCVP | 02 | N | 10386677 | BCG |
| 10008048 | 10004155 | 1.74 | 0 | Palliative (P) | 2018-06-19 | 2018-07-08 | Carboplatin + Vinorelbine IV | N | N | 10408776 | BCG |
| 10008049 | 10004156 | 1.69 | 72 | Disease modification (D) | 2018-02-27 | 2018-03-13 | GemCarbo Days 1+8 | null | Y | 10408810 | IBRUTINIB |
| 10008050 | 10004157 | 1.67 | 75.2 | Palliative (P) | 2018-09-15 | 2018-09-15 | Azacitidine | N | null | 10408938 | AZACITIDINE |
| 10008051 | 10004158 | 1.74 | 128.8 | Adjuvant (A) | 2015-07-10 | 2017-04-16 | Carboplatin + Pemetrexed | N | N | 10409013 | CARBOPLATIN + PEMETREXED |
| 10008052 | 10004158 | 1.59 | 80.7 | Not known (9) | 2016-07-04 | 2016-08-23 | Trial Unspecified | N | N | 10409013 | TRIAL |
| 10008053 | 10004161 | 1.56 | 85.5 | Palliative (P) | 2017-09-02 | 2017-12-14 | CARBOPLATIN + ETOPOSIDE | N | N | 10409174 | CARBOPLATIN + ETOPOSIDE |
| 10008054 | 10004165 | 1.73 | null | Adjuvant (A) | 2016-02-20 | 2016-05-14 | Trial Unspecified | 02 | N | 10409290 | TRIAL |
| 10008055 | 10007185 | 1.83 | 84.2 | Adjuvant (A) | 2015-08-21 | 2015-08-21 | Bevacizumab | N | N | 10409858 | CARBOPLATIN |
| 10008056 | 10004168 | 1.78 | 74.7 | Curative (C) | 2018-01-16 | 2018-01-20 | Capecitabine | N | N | 10410097 | CAPECITABINE |
| 10008057 | 10004171 | null | 53.8 | Disease modification (D) | 2013-11-17 | 2013-12-22 | BENDAMUSTINE + RITUXIMAB | N | N | 10410233 | BENDAMUSTINE + RITUXIMAB |
| 10008058 | 10004173 | 1.71 | 77 | Palliative (P) | 2017-04-19 | 2017-04-22 | Trial Unspecified | N | N | 10410299 | TRIAL |
| 10008059 | 10004174 | 1.79 | null | Palliative (P) | 2015-04-09 | 2015-05-29 | Carboplatin + Etoposide iv&po | N | N | 10410582 | CARBOPLATIN + ETOPOSIDE |
| 10008060 | 10004176 | 1.87 | 77 | Palliative (P) | 2017-04-03 | 2017-07-31 | Capecitabine | 02 | N | 10410849 | CAPECITABINE |
| 10008061 | 10007193 | 1.75 | 70.2 | Palliative (P) | 2017-07-13 | 2017-10-29 | CVP R | N | N | 10411394 | BCG |